Gilead soars on rising demand of Hepatitis C Drug, Sovaldi

July 24, 2014 12:46 PM

10 0

The powerful hepatitis C drug, Sovaldi, from Gilead Sciences Inc. that costs 1,000 dollar a day is expected to notch among the biggest sales ever for the first year of a newly approved drug.

Ted Tabor and Sandra Cabrera both suffered severely from hepatitis C, however after taking Gilead's Sovaldi, both of them felt better and medical tests show that the deadly virus is disappearing from their blood.

Also read: Tiger-backed hedge fund firm Tyrian to close, source says

Read more

To category page

Loading...